Document Detail


Prophylactic lidocaine in the early phase of suspected myocardial infarction.
MedLine Citation:
PMID:  3895875     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Four hundred two patients with suspected myocardial infarction seen within 6 hours of the onset of symptoms entered a double-blind randomized trial of lidocaine vs placebo. During the 1 hour after administration of the drug the incidence of ventricular fibrillation or sustained ventricular tachycardia among the 204 patients with acute myocardial infarction was low, 1.5%. Lidocaine, given in a 300 mg dose intramuscularly followed by 100 mg intravenously, did not prevent sustained ventricular tachycardia, although there was a significant reduction in the number of patients with warning arrhythmias between 15 and 45 minutes after the administration of lidocaine (p less than 0.05). The average plasma lidocaine level 10 minutes after administration for patients without a myocardial infarction was significantly higher than that for patients with an acute infarction. The mean plasma lidocaine level of patients on beta-blocking agents was no different from that in patients not on beta blocking agents. During the 1-hour study period, the incidence of central nervous system side effects was significantly greater in the lidocaine group, hypotension occurred in 11 patients, nine of whom had received lidocaine, and four patients died from asystole, three of whom had had lidocaine. We cannot advocate the administration of lidocaine prophylactically in the early hours of suspected myocardial infarction.
Authors:
H M Dunn; J M McComb; C D Kinney; N P Campbell; R G Shanks; G MacKenzie; A A Adgey
Related Documents :
1381305 - The prognostic significance of very low frequency ventricular ectopic activity in survi...
4103275 - Effects of lignocaine and propranolol on experimental cardiac arrhythmias.
7113895 - Effects of epinephrine on the electrophysiologic properties of purkinje fibers survivin...
1683045 - Evidence for or against the efficacy of calcium channel blockers for management of hype...
9391285 - Long-term follow up of patients with implantable cardioverter-defibrillators and mild, ...
12573275 - Time-based risk assessment after myocardial infarction. implications for timing of disc...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American heart journal     Volume:  110     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1985 Aug 
Date Detail:
Created Date:  1985-09-09     Completed Date:  1985-09-09     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  353-62     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Arrhythmias, Cardiac / prevention & control
Brain Diseases / chemically induced
Cardiovascular Diseases / chemically induced
Clinical Trials as Topic
Creatine Kinase / blood
Double-Blind Method
Electrocardiography
Female
Humans
Injections, Intramuscular
Lidocaine / adverse effects,  blood,  therapeutic use*
Male
Middle Aged
Myocardial Infarction / complications,  drug therapy*
Random Allocation
Tachycardia / prevention & control
Time Factors
Ventricular Fibrillation / etiology,  prevention & control*
Chemical
Reg. No./Substance:
137-58-6/Lidocaine; EC 2.7.3.2/Creatine Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neonatal sepsis.
Next Document:  Assessment of the severity of valvular regurgitation by digital subtraction angiography compared to ...